NASDAQ · Health care

Genprex, Inc. (GNPX)

It posted a net loss of $16.5M. At June 30, 2026 it held $15.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What Genprex, Inc. does

Genprex, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GNPX.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$15.5M	-$16.2M	-$17.40	n/a
2024	$0	-$21.2M	-$21.1M	-$266.89	n/a
2023	$0	-$31.1M	-$30.9M	-$1,127.54	n/a
2022	$0	-$23.8M	-$23.7M	-$989.59	-$17.6M
2021	$0	-$20.7M	-$20.7M	-$20.99	-$14.3M
2020	$0	-$18M	-$17.9M	-$25.49	-$14M

Full financial statements: income, balance sheet and cash flow

Next report expected around October 22, 2026.

Estimated from its filing rhythm: about 69 days after its last report of August 14, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Genprex, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 18, 2026
Other event 8-K
August 14, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$9.40 versus -$185.30.
August 5, 2026
Stock exchange listing notice 8-K
August 3, 2026
Other event 8-K
July 30, 2026
Stock exchange listing notice 8-K
July 14, 2026
Shareholder rights changed 8-K
June 26, 2026
Employee stock plan registration S-8
June 22, 2026
Other event 8-K
June 18, 2026
Executive or director change 8-K
June 12, 2026
Stock exchange listing notice 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 15, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about GNPX

What does Genprex, Inc. do?

Genprex, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GNPX.

Is Genprex, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $16.5M.

When did Genprex, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from August 18, 2026.

Similar companies

Compare GNPX with

Compare GNPX with any company

Follow GNPX

Get an email when Genprex, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow GNPX: get an email when it files

Where the numbers come from

Financial figures are the values Genprex, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.